Close Menu

Stanford

Mark Schmeizl, David Sneider, David Cox, Joshua LaBaer

Elias Zerhouni has joined the Gates Foundation, Aushon Biosystems has named a new VP of North American Sales, Joshua LaBaer heads West to Arizona State University, and more.

A paper appearing in today's issue of NEJM demonstrates that combining genetic and clinical data can improve stable warfarin dose predictions — especially for those taking high or low doses of the drug. Now, large clinical trials in the US and Europe are slated to test the effect such dosing improvements have on clinical outcomes.

Pairings: Feb 18, 2009

Premium

Alan Carter, David Cox, John Alsobrook

Short Reads: Feb 17, 2009

Premium

Life Technologies, Max Planck Institute for Evolutionary Anthropology, 454 Life Sciences, Applied Biosystems, Baylor College of Medicine, University of Bristol, University of Liverpool, John Innes Centre, Helicos BioSciences, Febit, and more…

In a talk at the AAAS meeting in Chicago, Stanford University bioengineer Drew Endy said that the US needs a national initiative to support and encourage synthetic biology.

Helicos filed the prospectus for 68.4 million shares held by investors who participated in a private placement in December. The firm would receive none of the proceeds from the sale of those shares, if any of them are sold.

Ocarina Networks said this week that Cornell University's Center for Advanced Computing is testing its system for compressing large amounts of life-science data, including data from second-generation sequencers.

Funding Update: Feb 3, 2009

Premium

Sequencing-Related NIH Grants, Nov. 4, 2008 — Feb. 2, 2009

Short Reads: Feb 3, 2009

Premium

Broad Institute, Expression Analysis, Helicos BioSciences, University of Texas at Austin, Applied Biosystems, University of Georgia, ABRF, Genomatix, Illumina, Mondobiotech, 23andMe, Kapa Biosystems

Pages

23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.

He Jiankui is no longer affiliated with Direct Genomics Biotechnology, the single molecule sequencing company he founded, Nikkei Asian Review reports.

Newsweek writes about the hopes for precision medicine in cancer, but also challenges getting it to patients.

In Genome Research this week: genomic architecture of glioblastoma, predictive computational approach to estimate SNP fitness, and more.